15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ 2) promotes apoptosis of HBx-positive liver cells

Chemico-Biological Interactions

Volumn 214, Issue 1, 2014, Pages 26-32

  Chen, Siyan ^a   Liu, Chong ^a   Wang, Xiaoqian ^a   Li, Xiujin ^a   Chen, Yanling ^a   Tang, Nanhong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; HBx; Liver cell

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CAY 10526; HEPATITIS B VIRUS X PROTEIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; IC 50; INFLAMMATION; LIVER CELL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION;

15D-PGJ(2); APOPTOSIS; HBX; LIVER CELL;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; COLORIMETRY; DINOPROSTONE; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; LIVER; POLYMERASE CHAIN REACTION; PROSTAGLANDIN D2; TRANS-ACTIVATORS;

EID: 84896261949     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.02.009     Document Type: Article

References (38)

1. C. Maletzki, and J. Emmrich Inflammation and immunity in the tumor environment Dig. Dis. 28 2010 574 578
2. Y. Matsuda, and T. Ichida Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis Med. Mol. Morphol. 42 2009 138 142
3. X. Zhang, H. Zhang, and L. Ye Effects of hepatitis B virus X protein on the development of liver cancer J. Lab. Clin. Med. 147 2006 58 66 (Pubitemid 43188997)
4. A.S. Cheng, H.L. Chan, W.K. Leung, K.F. To, M.Y. Go, and J.Y. Chan et al. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2 Mod. Pathol. 17 2004 1169 1179 (Pubitemid 39312943)
5. H.Z. Lu, J.H. Zhou, and M. Pongsavee Hepatitis B virus X protein up-regulates tumor necrosis factor-alpha expression in cultured mesangial cells via ERKs and NF-kappaB pathways Asian Pac. J. Trop. Biomed. 3 2013 217 222
6. Y.H. Park, H.J. Shin, S.U. Kim, J.M. Kim, J.H. Kim, and D.H. Bang et al. iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation Biochem. Biophys. Res. Commun. 435 2013 244 249
7. L. Chen, L. Hu, L. Li, Y. Liu, Q.Q. Tu, and Y.X. Chang et al. Dysregulation of beta-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas Front. Med. China 4 2010 399 411
8. C.T. Bock, N.L. Toan, B. Koeberlein, H. Song le, R. Chin, and H. Zentgraf et al. Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma Intervirology 51 2008 432 443
9. Z. Hou, G. Liu, F. Zheng, and D. Tan HBx gene inducing hepatocellular carcinoma in vivo and its mechanism Zhong Nan Da Xue Xue Bao Yi Xue Ban 34 2009 282 288
10. H. Tang, N. Oishi, S. Kaneko, and S. Murakami Molecular functions and biological roles of hepatitis B virus x protein Cancer Sci. 97 2006 977 983 (Pubitemid 44322542)
11. J.Y. Tang, M. Aszterbaum, M. Athar, F. Barsanti, C. Cappola, and N. Estevez et al. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice Cancer Prev. Res. (Phila.) 3 2010 25 34
12. D.W. Fitzgerald, K. Bezak, O. Ocheretina, C. Riviere, T.C. Wright, and G.L. Milne et al. The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels Cancer Prev. Res. (Phila.) 5 2012 34 40
13. H. Xie, L. Gao, N. Chai, J. Song, J. Wang, and Z. Song et al. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib Mol. Carcinog. 48 2009 56 65
14. J. Cheng, H. Imanishi, H. Morisaki, W. Liu, H. Nakamura, and T. Morisaki et al. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1 J. Hepatol. 43 2005 465 471 (Pubitemid 41111428)
15. D. Bruemmer, J.P. Berger, J. Liu, U. Kintscher, S. Wakino, and E. Fleck et al. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth Eur. J. Pharmacol. 466 2003 225 234 (Pubitemid 36412085)
16. D. Shen, C. Deng, and M. Zhang Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells Postgrad. Med. J. 83 2007 414 419 (Pubitemid 46960828)
17. F.M. Suk, C.H. Chen, S.Y. Lin, C.J. Cheng, S.J. Yen, and L.F. Hung et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells Toxicol. Lett. 187 2009 22 27
18. H.Y. Chen, N.H. Tang, N. Lin, Z.X. Chen, and X.Z. Wang Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses Hepatol. Res. 38 2008 174 182
19. H. Tang, L. Delgermaa, F. Huang, N. Oishi, L. Liu, and F. He et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication J. Virol. 79 2005 5548 5556 (Pubitemid 40548223)
20. D.H. Li, X.P. Chen, W.G. Zhang, and F.Z. Qiu HBx gene facilitates the proliferation activity of hepatoma cells in vitro and in vivo Zhonghua Wai Ke Za Zhi 42 2004 104 106
21. A. Krueger, S. Baumann, P.H. Krammer, and S. Kirchhoff FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis Mol. Cell. Biol. 21 2001 8247 8254 (Pubitemid 33108586)
22. S. Rawat, A.J. Clippinger, and M.J. Bouchard Modulation of apoptotic signaling by the hepatitis B virus X protein Viruses 4 2012 2945 2972
23. C. Shan, F. Xu, S. Zhang, J. You, X. You, and L. Qiu et al. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2 Cell Res. 20 2010 563 575
24. M. Hughes-Fulford, C.F. Li, J. Boonyaratanakornkit, and S. Sayyah Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer Cancer Res. 66 2006 1427 1433 (Pubitemid 43259923)
25. T. Morisaki, M. Umebayashi, A. Kiyota, N. Koya, H. Tanaka, and H. Onishi et al. Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro Anticancer Res. 33 2013 1387 1395
26. Y.Q. Li, S.M. Yin, D.N. Nie, S.F. Xie, L.P. Ma, and X.J. Wang et al. Effect of mPGES-1 inhibitor MK886 on apoptosis and drug resistance of HL-60/A cells Zhongguo Shi Yan Xue Ye Xue Za Zhi 20 2012 829 834
27. B. Zhong, H. Shen, X. Sun, H. Wang, Y. Zhang, and Z. Sun Additive effects of ulinastatin and docetaxel on growth of breast cancer xenograft in nude mice and expression of PGE2, IL-10, and IL-2 in primary breast cancer cells Cancer Biother. Radiopharm. 27 2012 252 258
28. Q. Wu, W. Chang, C.C. Zhu, L.R. Fan, and S.Z. Song Effect of NS-398 on cyclooxygenase-2 expression and proliferation of HepG2 cells Zhonghua Yu Fang Yi Xue Za Zhi 42 2008 260 263
29. P. Reyes-Martin, S. Ramirez-Rubio, T. Parra-Cid, R. Bienes-Martinez, and J. Lucio-Cazana 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism Pharmacol. Res. 57 2008 344 350
30. T. Kadowaki, K. Hara, N. Kubota, K. Tobe, Y. Terauchi, and T. Yamauchi et al. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance J. Diabetes Complications 16 2002 41 45 (Pubitemid 34168499)
31. Z.S. Nagy, Z. Czimmerer, A. Szanto, and L. Nagy Pro-inflammatory cytokines negatively regulate PPARgamma mediated gene expression in both human and murine macrophages via multiple mechanisms Immunobiology 2013
32. X. Pang, Y. Wei, Y. Zhang, M. Zhang, Y. Lu, and P. Shen Peroxisome proliferator-activated receptor-gamma activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1 Cancer Sci. 104 2013 672 680
33. M.K. Sakharkar, B. Shashni, K. Sharma, S.K. Dhillon, P.R. Ranjekar, and K.R. Sakharkar Therapeutic implications of targeting energy metabolism in breast cancer PPAR Res. 2013 2013 109285
34. D. Wang, and R.N. DuBois Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer Gastroenterol. Clin. North Am. 39 2010 697 707
35. X.J. Zeng, X.C. Bi, Q.S. Dai, Z.D. Han, and W.D. Zhong Effects of PPAR-gamma on the proliferation and glycolysis metabolism of prostate cancer cells Zhonghua Nan Ke Xue 18 2012 692 696
36. A. Fucci, T. Colangelo, C. Votino, M. Pancione, L. Sabatino, and V. Colantuoni The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer PPAR Res. 2012 2012 242498
37. M.Y. Li, H. Deng, J.M. Zhao, D. Dai, and X.Y. Tan PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells World J. Gastroenterol. 9 2003 1220 1226 (Pubitemid 36805656)
38. Y.H. Choi, H.I. Kim, J.K. Seong, D.Y. Yu, H. Cho, and M.O. Lee et al. Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein interaction FEBS Lett. 557 2004 73 80 (Pubitemid 38115872)